Fingerprint
Dive into the research topics of 'A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
HS Walter, SA Rule, MJS Dyer, L Karlin, C Jones, B Cazin, P Quittet, N Shah, CV Hutchinson, H Honda, K Duffy, J Birkett, V Jamieson, N Courtenay-Luck, T Yoshizawa, J Sharpe, T Ohno, S Abe, A Nishimura, G Cartron
Research output: Contribution to journal › Article › peer-review